Karl J Erlandson
Overview
Explore the profile of Karl J Erlandson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White R, Kovacs G, Chandran S, Adams P, Britson K, Cao H, et al.
Health Secur
. 2025 Jan;
23(1):47-54.
PMID: 39882823
The COVID-19 pandemic has revealed the need for nations to prepare more effectively for emerging infectious diseases. Preparing for these threats requires a multifaceted approach that includes assessing pathogen threat,...
2.
Lusvarghi S, Pollett S, Neerukonda S, Wang W, Wang R, Vassell R, et al.
Sci Transl Med
. 2022 Apr;
14(645):eabn8543.
PMID: 35380448
The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene has raised...
3.
Lusvarghi S, Pollett S, Neerukonda S, Wang W, Wang R, Vassell R, et al.
bioRxiv
. 2022 Jan;
PMID: 34981057
One Sentence Summary: Third dose of Pfizer/BioNTech COVID-19 vaccine significantly boosts neutralizing antibodies to the Omicron variant compared to a second dose, while neutralization of Omicron by convalescent sera, two-dose...
4.
Neerukonda S, Vassell R, Lusvarghi S, Wang R, Echegaray F, Bentley L, et al.
Viruses
. 2021 Dec;
13(12).
PMID: 34960755
The SARS-CoV-2 B.1.617 lineage variants, Kappa (B.1.617.1) and Delta (B.1.617.2, AY) emerged during the second wave of infections in India, but the Delta variants have become dominant worldwide and continue...
5.
Neerukonda S, Vassell R, Lusvarghi S, Wang R, Echegaray F, Bentley L, et al.
bioRxiv
. 2021 Nov;
PMID: 34790980
The SARS-CoV-2 B.1.617 lineage variants, Kappa (B.1.617.1) and Delta (B.1.617.2, AY) emerged during the second wave of infections in India, but the Delta variants have become dominant worldwide and continue...
6.
Lusvarghi S, Wang W, Herrup R, Neerukonda S, Vassell R, Bentley L, et al.
J Virol
. 2021 Oct;
96(1):e0111021.
PMID: 34668774
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor binding...
7.
de Wit E, Feldmann F, Okumura A, Horne E, Haddock E, Saturday G, et al.
Antiviral Res
. 2018 Jun;
156:64-71.
PMID: 29885377
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for an effective treatment to reduce the disease severity and mortality. REGN3051 and REGN3048 are two fully human...
8.
Uyeki T, Erlandson K, Korch G, OHara M, Wathen M, Hu-Primmer J, et al.
Emerg Infect Dis
. 2016 May;
22(7).
PMID: 27191188
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human...
9.
Erlandson K, Bisht H, Weisberg A, Hyun S, Hansen B, Fischer E, et al.
Cell Rep
. 2016 Mar;
14(9):2084-2091.
PMID: 26923595
Poxviruses are enveloped DNA viruses that replicate within the cytoplasm. The first viral structures are crescents and spherical particles, with a lipoprotein membrane bilayer, that are thought to be derived...
10.
Mendez-Rios J, Yang Z, Erlandson K, Cohen J, Martens C, Bruno D, et al.
J Virol
. 2016 Feb;
90(9):4469-4480.
PMID: 26889040
Unlabelled: Molluscum contagiosum virus (MOCV), the only circulating human-specific poxvirus, has a worldwide distribution and causes benign skin lesions that may persist for months in young children and severe infections...